[1] Chen L, Yang P, Zhang M, Dai WF. Two new sesquiterpenes from Xylopia vielana. Nat Prod Res. 2023;37(7):1199-204. [2] Guo YG, Ding YH, Wu GJ, Zhu SL, Sun YF, Yan SK, et al. Three new alkaloids from Xylopia vielana and their antiinflammatory activities. Fitoterapia. 2018;127:96-100. [3] Guo YG, Xie YG, Wu GJ, Cheng TF, Zhu SL, Yan SK, et al. Xylopidimers A-E, five new guaiane dimers with various carbon skeletons from the roots of Xylopia vielana. ACS Omega. 2019;4(1):2047-52. [4] Kamperdick C, Phuong NM, Van Sung T, Adam G. Guaiane dimers from Xylopia vielana. Phytochemistry. 2001;56:335-40. [5] Kamperdick C, Phuong NM, Adam G, Van Sung T. Guaiane dimers from Xylopia vielana. Phytochemistry. 2003;64:811-6. [6] Xie YG, Guo YG, Wu GJ, Zhu SL, Cheng TF, Zhang Y, et al. Xylopsides A-D, four rare guaiane dimers with two unique bridged pentacyclic skeletons from Xylopia vielana. Org Biomol Chem. 2018;16(37):8408-12. [7] Xie YG, Wu GJ, Cheng TF, Zhu SL, Yan SK, Jin HZ, et al. Vielopsides A-E, five new guaiane-type sesquiterpenoid dimers from Xylopia vielana. Fitoterapia. 2018;130:43-7. [8] Xie YG, Zhang WY, Zhu SL, Cheng TF, Wu GJ, Muhammad I, et al. Xyloplains A-F, six new guaiane-type sesquiterpenoid dimers from Xylopia vielana. RSC Adv. 2018;8(45):25719-24. [9] Xie YG, Yan R, Zhong XL, Piao H, Muhammad I, Ke XS, et al. Xylopins A-F, six rare guaiane dimers with three different connecting modes from Xylopia vielana. RSC Adv. 2019;9(16):9235-42. [10] Xie YG, Zhong XL, Xiao YZ, Zhu SL, Muhammad I, Yan SK, et al. Vieloplains A-G, seven new guaiane-type sesquiterpenoid dimers from Xylopia vielana. Bioorg Chem. 2019;88:102891. [11] Xu QQ, Zhang C, Zhang YL, Lei JL, Kong LY, Luo JG. Dimeric guaianes from leaves of Xylopia vielana as snail inhibitors identified by high content screening. Bioorg Chem. 2021;108:104646. [12] Zhang YL, Zhou XW, Wang XB, Wu L, Yang MH, L J, et al. Xylopiana A, a dimeric guaiane with a case-shaped core from Xylopia vielana: structural elucidation and biomimetic conversion. Org Lett. 2017;9(11):3013-6. [13] Zhang YL, Xu QQ, Zhou XW, Wu L, Wang XB, Yang MH, et al. Rare dimeric guaianes from Xylopia vielana and their multidrug resistance reversal activity. Phytochemistry. 2019;158:26-34. [14] Halgren TA. MMFF VI. MMFF94s option for energy minimization studies. J Comput Chem. 1999;20(7):720-9. [15] Bruhn T, Schaumoffel A, Hemberger Y, Bringmann G. SpecDis: quantifying the comparison of calculated and experimental electronic circular dichroism spectra. Chirality. 2013;25(4):243-9. [16] Wu WY, Wei X, Liao Q, Fu YF, Wu LM, Li L, et al. Structurally diverse polyketides and alkaloids produced by a plant-derived fungus Penicillium canescens L1. Nat Prod Bioprospect. 2025;15(1):22. [17] Chen YM, Cao NK, Zhu SS, Ding M, Liang HZ, Zhao MB, et al. Euchrestifolines A-O, fifteen novel carbazole alkaloids with potent anti-ferroptotic activity from Murraya euchrestifolia. Nat Prod Bioprospect. 2025;15(1):5. [18] Gao HL, Xia YZ, Zhang YL, Yang L, Kong LY. Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines. Phytomedicine. 2019;58:152885. [19] Tan Q, Hu K, Li XN, Yang XZ, Sun HD, Puno PT. Cytotoxic C-20 non-oxygenated ent-kaurane diterpenoids from Isodon wardii. Bioorg Chem. 2023;135:106512. [20] Wu Y, Zhang B, Li W, Peng L, Qiao W, Li W, et al. Asprecosides A-J, ten new pentacyclic triterpenoid glycosides with cytotoxic activity from the roots of Ilex asprella. Nat Prod Bioprospect. 2025;15(1):18. [21] Wei R, Zhao Y, Wang J, Yang X, Li S, Wang Y, et al. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. Int J Biol Sci. 2021;17(11):2703-17. [22] Kim GJ, Yang EJ, Kim YS, Moon J, Son YK, Nam JW, et al. Diterpene and biflavone derivatives from Thuja koraiensis and their cytotoxicities against A549 cells. Phytochemistry. 2023;211:113711. [23] Liu L, Shi D, Xia ZY, Wang BW, Wang XL, Wang XT, et al. Gamabufotalin induces apoptosis and cytoprotective autophagy through the mTOR signaling pathway in hepatocellular carcinoma. J Nat Prod. 2023;86(4):966-78. [24] Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer. Nat Rev Mol Cell Biol. 2022;23(1):74-88. [25] Yang C, Chen XC, Li ZH, Wu HL, Jing KP, Huang XR, et al. SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy. Autophagy. 2021;17(9):2325-44. [26] He XF, Li QH, Li TZ, Ma YB, Dong W, Yang KX, et al. Artemeriopolides A-D, two types of sesquiterpenoid dimers with rare carbon skeletons from Artemisia eriopoda and their antihepatoma cytotoxicity. Org Chem Front. 2023;10(11):2635-41. [27] Xu HY, Liu JQ, Li XK, Li JW, Lin X, Li ZW, et al. Instrumental and transcriptome analysis reveals the chemotherapeutic effects of doxorubicin-loaded black phosphate nanosheets on abiraterone-resistant prostate cancer. Bioorg Chem. 2023;137:106583. [28] Lee SY, Choi SH, Kim Y, Ahn HS, Ko YG, Kim K, et al. Migrasomal autophagosomes relieve endoplasmic reticulum stress in glioblastoma cells. BMC Biol. 2024;22(1):23. [29] Hilmi F, Gertsch J, Bremner P, Valovic S, Heinrich M, Sticher O, et al. Cytotoxic versus anti-inflammatory effects in HeLa, Jurkat T and human peripheral blood cells caused by guaianolide-type sesquiterpene lactones. Bioorg Med Chem. 2003;11(17):3659-63. [30] Rozenblat S, Grossman S, Bergman M, Gottlieb H, Cohen Y, Dovrat S. Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines. Biochem Pharmacol. 2008;75(2):369-82. [31] Xue GM, Zhu DR, Zhu TY, Wang XB, Luo JG, Kong LY. Lactone ring-opening seco-guaianolide involved heterodimers linked via an ester bond from Artemisia argyi with NO inhibitory activity. Fitoterapia. 2019;132:94-100. [32] Ma LF, Chen YL, Shan WG, Zhan ZJ. Natural disesquiterpenoids: an update. Nat Prod Rep. 2020;37(7):999-1030. [33] Su L, Zhang X, Ma Y, Geng C, Huang X, Hu J, et al. New guaiane-type sesquiterpenoid dimers from Artemisia atrovirens and their antihepatoma activity. Acta Pharm Sin B. 2021;11(6):1648-66. [34] Qin JJ, Sarkar S, Voruganti S, Agarwal R, Wang W, Zhang R. Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy. J Biomed Res. 2016;30(4):322-33. [35] Qin JJ, Li X, Wang W, Zi X, Zhang R. Targeting the NFAT1-MDM2-MDMX network inhibits the proliferation and invasion of prostate cancer cells, independent of p53 and androgen. Front Pharmacol. 2017;8:917. [36] Qin JJ, Wang W, Sarkar S, Voruganti S, Agarwal R, Zhang R. Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy. Oncotarget. 2016;7(22):32566-78. |